Table 2.
Correlations between the variables and return to target erectile function (International Index of Erectile Function-5 ≥17), and between the variables and effective shortening of the patient’s penis (shortening ≥1 cm) after 12 months of intervention were analyzed using logistic regression
| Predictor | OR (95% CI) | P |
|---|---|---|
| IIEF-5 ≥17 | ||
| Age (year) | 0.974 (0.886–1.070) | 0.597 |
| BMI (kg m−2) | 1.030 (0.845–1.257) | 0.768 |
| PSA (ng ml−1) | 0.966 (0.858–1.089) | 0.575 |
| Gleason score | 1.362 (0.466–3.983) | 0.573 |
| Baseline IIEF-5 | 1.188 (0.914–1.544) | 0.198 |
| PLNES (cm) | 1.005 (0.704–1.434) | 0.979 |
| Penis shortening ≥1 cm | ||
| Age (year) | 1.056 (0.972–1.148) | 0.199 |
| BMI (kg m−2) | 1.110 (0.926–1.330) | 0.261 |
| PSA (ng ml−1) | 1.054 (0.955–1.163) | 0.297 |
| Gleason score | 1.923 (0.773–4.781) | 0.159 |
| Baseline IIEF-5 | 0.950 (0.783–1.154) | 0.607 |
| PLNES (cm) | 1.245 (0.919–1.687) | 0.157 |
BMI: body mass index; PLNES: penile length in non-erection state; PSA: prostate-specific antigen; CI: confidence interval; IIEF-5: International Index of Erectile Function-5; OR: odds ratio